Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Chaudhuri (Glasgow, United Kingdom), A. Rubin (Porto Alegre, Brazil), J. Fiterman (Porto Alegre, Brazil), K. Sumino (St. Louis, MO, United States of America), J. Lapa E Silva (Rio de Janiero, Brazil), R. Niven (Manchester, United Kingdom), S. Siddiqui (Leicester, United Kingdom), R. Olivenstein (Montreal, QC, Canada), K. Klooster (Groningen, Netherlands), C. Mcevoy (St. Paul, MN, United States of America), P. Shah (London, United Kingdom), M. Simoff (Detroit, MI, United States of America), D. Duhamel (Arlington, VA, United States of America), S. Khatri (Cleveland, OH, United States of America), R. Barbers (Los Angeles, CA, United States of America), F. Nolan (Marlborough, MA, United States of America), M. Laviolette (Quebec, QC, Canada). Ten-year follow-up of subjects who received bronchial thermoplasty (BT) in 3 randomized controlled studies (BT10+). 3782

Member's Comments

No comment yet.

Related content which might interest you: BT10+ study design: 10 year follow-up of subjects receiving bronchial thermoplasty (BT) in 3 randomized controlled studies Source: International Congress 2017 – To freeze or heat? Year: 2017 Reslizumab (RES) in patients (pts) with inadequately controlled asthma and elevated blood eosinophils (EOS): Analysis of two phase 3, placebo-controlled trials Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Whole body vibration training in long-term (>1 year) lung transplant patients – A randomized, controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017 Fixed combination of glycopyrrolate and formoterol MDI (GFF-MDI) demonstrates superior inspiratory capacity (IC) compared to tiotropium DPI (Tio) following 7 days dosing, in a randomized, double-blind, placebo-controlled phase 2b study in patients with COPD Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 LATE-BREAKING ABSTRACT: Treating the most diseased segments in patients with severe emphysema: 6 month results from the STEP-UP randomized controlled trial (RCT) Source: International Congress 2015 – Advances in therapeutic bronchoscopy Year: 2015 Comparison against baseline in randomised control trials (again) Source: Eur Respir J 2014; 44: 1376 Year: 2014 Comparison against baseline in randomised control trials (again) Source: Eur Respir J 2014; 44: 1376-1377 Year: 2014 Randomized, double blind, double dummy, placebo-controlled trial designed for comparing the effectiveness of formoterol (Foradil®) Aerolizer® and ipatropium bromide plus nebulized fenoterol (Berodual®) in asthma patients with ages ranging between 5 and 12 years who suffer acute asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 The effect of high dose N-acetylcysteine (1200mg daily) on airway function and airway trapping in COPD patients — A double blinded randomized placebo controlled trial Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012 Effect of salmetrol-fluticason combination and tiotropium on clinical and physiological improvement of bronchial anthracofibrosis, a double blind randomized, cross over, placebo controlled, clinical trial. Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with medium-dose ICS/LABA therapy (on GINA step 4) prior to study entry: Results from IRIDIUM study Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 LATE-BREAKING ABSTRACT: A multicenter, prospective, randomized, controlled trial of endobronchial valve therapy vs standard of care in homogeneous emphysema (IMPACT) Source: International Congress 2016 – Endoscopic lung volume reduction I Year: 2016 Mometasone/indacaterol (MF/IND) and mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus fluticasone/salmeterol (FLU/SAL) and FLU/SAL+tiotropium (TIO) in patients with inadequately controlled asthma: data from the PLATINUM program Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with high-dose ICS/LABA therapy (on GINA step 5) prior to study entry: Results from IRIDIUM study Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 PULSAR: A phase 2, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of sotatercept (ACE-011) when added to standard of care (SOC) for treatment of pulmonary arterial hypertension (PAH) Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Efficacy of bronchial thermoplasty (BT) in patients with severe asthma: the AIR2 trial Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 The evaluation of the efficacy and safety of phospholipids‘ inhalation in patients with bronchial asthma (BA): A prospective randomized placebo-controlled study Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 A randomised, double-blind, placebo-controlled phase 3 study investigating the efficacy of nicotine substitution (NS) on nicotine withdrawal symptoms (NWS) in hospitalised smokers (HS) Source: Annual Congress 2009 - Smoking cessation Year: 2009 Buteyko technique (BT) as an adjunct in pulmonary rehabilitation (PR) in patients with asthma and dysfunctional breathing – First results of an ongoing prospective controlled study Source: Annual Congress 2012 - New adjuncts and modalities in pulmonary rehabilitation Year: 2012 Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX) Source: International Congress 2018 – Paediatric asthma: prevention, diagnosis and treatment Year: 2018